Crossmark

Safety and Efficacy of Mirogabalin in Lumbar Spinal Stenosis Patients with Peripheral Neuropathic Pain on NSAIDs: Post Hoc Analysis of the MiroTAS Study

Crossref DOI link: https://doi.org/10.1007/s40122-025-00732-8

Published Online: 2025-05-07

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nikaido, Takuya

Tabata, Shunsuke

Shiosakai, Kazuhito

Nakatani, Taichi

Sakoda, Hiroshi
Funding

Funding for this research was provided by:

Daiichi-Sankyo
License Information

Text and Data Mining valid from 2025-05-07

Version of Record valid from 2025-05-07
More Information

Article History

Received: 9 December 2024

Accepted: 14 March 2025

First Online: 7 May 2025

Declarations

:

: Takuya Nikaido received lecture fees from Daiichi Sankyo Co., Ltd. Shunsuke Tabata, Kazuhito Shiosakai, and Hiroshi Sakoda are employees of Daiichi Sankyo Co., Ltd. Taichi Nakatani is an employee of EPS Corporation.

: The primary study was approved by the Clinical Research Review Committee, Fukushima Medical University Certified Review Board (CRB No. CRB2200002), which notified all participating centers of the approval. The primary study was conducted in accordance with the ethical principles, Clinical Trials Act, and relevant notifications stipulated in the Declaration of Helsinki (as revised in 2013). All patients provided written informed consent. The primary study was registered in the Japan Registry of Clinical Trials under the identifier jRCTs021200007.

Document is current

Any future updates will be listed below